BMO Capital Markets' Andrew Kaip Says Get Ready for the Consolidation Wave
Source: Brian Sylvester of The Gold Report  (12/22/14)
Andrew Kaip, managing director of mining equity research at BMO Capital Markets, says the stark reality is that the precious metals sector is only part way through a down cycle and that structural issues will result in a fresh phase of consolidation. He adds that the small to intermediate producers will lead the consolidation charge. In this interview with The Gold Report, Kaip suggests some suitors and prime acquisition candidates. More >

The Best Biotech Stocks to Buy in 2015
Source: Kyle Anderson, Money Morning  (12/22/14)
Market corrections are always a possibility – especially in biotech, which is one of the more volatile sectors. That's why the most important thing for investors in 2015 is finding companies with real value. Biotech companies that make good drugs that meet critical needs will be the sector's best profit opportunities. More >

The Many Phases of Silver
Source: Visual Capitalist  (12/19/14)
Since the early days of civilization, the ancients connected the brilliance of silver to the moon. Artemis, the Greek goddess of the moon, wore silver sandals and shot from a silver bow and arrow. This lunar comparison might be fitting because like the moon, silver also has many phases. The properties of silver make it the most dynamic of precious metals. More >

Gold 2015: A Quick Heads-Up
Source: Adrian Ash, BullionVault  (12/19/14)
Gold in 2015 will find mine output slowing, the dollar rally questioned and China's demand ever more important. . . More >

Turbulent Times Call for Insulated Investments: Steven Salz
Source: Tom Armistead of The Energy Report  (12/18/14)
Turbulence and volatility are in Steven Salz's forecast for the energy market. The special situations analyst at M Partners tells The Energy Report that falling oil prices are hurting oilfield services companies in different measures depending on their specialties, but that all are taking hits. A sign of the times: He thinks the Halliburton/Baker Hughes merger may be the first of a series of consolidations in the space. More >

2015 Small-Cap Biotech Watchlist Announced
Source: Staff of The Life Sciences Report  (12/18/14)
In its third year, The Life Sciences Report's 2015 Small-Cap Biotech Watchlist currently includes 12 drug development companies selected by leading analysts in the sector. With catalysts on the horizon and pipelines that encompass a variety of indications and innovative platforms, these biotechs are primed to return multiples on investment. More >

Doug Loe: Canada Has Earned Its Spot in the Biotech All-Star Team Photo
Source: George S. Mack of The Life Sciences Report  (12/18/14)
Biotech investors in the United States who overlook investment opportunities across the borders are missing out on huge opportunities, says Douglas Loe, healthcare equity analyst with Euro Pacific Canada. In this interview with The Life Sciences Report, Loe gives the Canadian life sciences industry an upbeat prognosis, and offers ideas on companies that could realize generous returns in the sector in 2015. More >

John Williams: A Downhill Run for the Dollar in 2015
Source: JT Long of The Gold Report  (12/17/14)
Rosy GDP numbers may have cheered the masses, but John Williams of ShadowStats.com says we're a long way from prosperity. In this interview with The Gold Report, Williams debunks the myth of economic recovery and warns that we still have serious debts to settle. That is why he is recommending caution in 2015 to preserve purchasing power and maintain your standard of living. More >

Have Gold and Silver Really Bottomed?
Source: Lawrence Williams, Mineweb  (12/17/14)
"The fundamentals seem to suggest that gold will move significantly upward rather than downward in the short to medium term." More >

Be Bold and Seek the Sizzle, Says VSA Capital's Paul Renken
Source: Brian Sylvester of The Mining Report  (12/16/14)
It's time to be bold, says Paul Renken, senior geologist and analyst with London-based VSA Capital. He seeks the "sizzle," or the narrative, in mining equities because the sizzle moves the story. But Renken remains selective and likes to see a significant discovery or acquisition that provides a clear path to investor returns. In this interview with The Mining Report, he recommends a veritable laundry list of companies in numerous commodities operating around the world. More >

Two Countries You Might Be Surprised to Find Hallgarten's Chris Ecclestone Likes Now
Source: Kevin Michael Grace of The Gold Report  (12/15/14)
How tight is money in the mining industry? So much so, according to Chris Ecclestone, mining strategist with Hallgarten & Co., that juniors are punished for resource estimates because the market believes they can't afford to develop their properties further. In this interview with The Gold Report, Ecclestone explains that canny juniors are choosing past-producing properties, which boast dependable resources estimated by majors and already existing infrastructure. And he names two current gold producers he believes are woefully undervalued. More >

The Copper Denominator: Gianni Kovacevic
Source: J. Alec Gimurtu of The Gold Report  (12/15/14)
Gianni Kovacevic, the author of "My Electrician Drives a Porsche?" and executive chairman of CopperBank Resources Corp., takes a scientific view of historical, social and environmental trends in energy usage and identifies copper as the common denominator. As global energy usage increases, most of that energy flows through copper. In this interview with The Gold Report, Kovacevic discusses how his book explains his approach in understanding copper's investment opportunity in a scientific context, and the role of the company he founded to take advantage of this secular trend. More >

BioPharm Executive: Top 7 Trends of 2014, with Predictions for 2015
Source: Karl Thiel, BioSpace.com  (12/15/14)
"The cancer immunotherapy area will heat up further. . .And while there won't be rush of approvals for RNAi, antisense, and gene therapy drugs in 2015, we'll get data that puts us a lot closer." More >

Wedbush Securities' David Nierengarten on Genetic Cures for Disease: Impossible Dream Come True?
Source: George S. Mack of The Life Sciences Report  (12/11/14)
Clinicians like to speak in terms of "managing" disease. That term of art is an admission that, in most cases, they can't cure the serious problems confronting patients. In this interview with The Life Sciences Report, David Nierengarten of Wedbush Securities explores gene therapies that actually correct an inborn mutation in human DNA, creating permanent change, actual cures and better lives for patients. It sounds beyond the reach of medicine. . .and therein lies the opportunity: Investors in gene therapy companies may capture serious returns on risk capital when the cure is attained. More >

Chen Lin: Low Oil Prices Fuel Bonanza Increases in Ethanol Stocks
Source: Kevin Michael Grace of The Energy Report  (12/11/14)
Chen Lin was one of the very few who foresaw the collapse in oil prices, so investors are well advised to pay attention to his advice. In this interview with The Energy Report,
the author of the What is Chen Buying? What is Chen Selling? newsletter touts the prospects of a few oil companies that can prosper in the downturn, and explains why cheap oil means high profits for U.S. ethanol producers. More >

Elliott Wave Charts Point to Shocking Countertrend for Gold: Steven Hochberg
Source: JT Long of The Gold Report  (12/10/14)
It's not just surfers who scrutinize wave patterns. Steven Hochberg, chief market analyst at Elliott Wave International, uses the Wave Principle to predict the movements of commodities and the stock market based on a number of factors, including sentiment. In this interview with The Gold Report, he reads the waves and sees indications that the stock market is headed for a downtrend, while commodities will move up, although not in a direct line.
More >

7 Companies 'Best Positioned to Deliver in 2015'
Source: Teresa Matich, Resource Investing News  (12/10/14)
"Despite the volatile market, there's definitely still some silver lining out there." More >

Rob Chang Spins Yellowcake into Gold and Gold into Green
Source: Peter Byrne of The Mining Report  (12/9/14)
The long winter of falling uranium prices is about to give way to a Japanese spring. In an interview with The Mining Report, Cantor Fitzgerald's Rob Chang discusses the return of the small producers as an increasingly hungry market looks to eat up all of the available uranium. Plus, Chang likes gold and enlightens us on how gold miners are shaking profits out of slag. More >

Robert Baylis: A Taste for Tungsten—Finding the Sweet Spot for Investors
Source: Brian Sylvester of The Gold Report  (12/8/14)
Finding the right combination of factors for an investable tungsten operation is no easy matter, says Robert Baylis, managing director of London-based Roskill. Much of the tungsten space is held privately, but some publicly traded equities offer leverage to future demand growth. In this interview with The Gold Report, Baylis says investor success in this space depends on finding that sweet spot where low capital and operating costs act as the honey needed to lure end users into offtake agreements or outright takeovers. More >

Gold Shorting Exhaustion
Source: Adam Hamilton, Zeal Intelligence  (12/6/14)
"Short selling always runs in relatively short spurts, ramping up fast but quickly peaking in selling exhaustion. And I suspect that's exactly what's happening in gold now." More >

Could Pinky the 'Super Mouse' End Alzheimer's?
Source: Ray Blanco, The Daily Reckoning  (12/5/14)
What would happen if you took Pinky and swapped some of his brain cells with human ones? As it turns out, what you might get is a really smart mouse. But that's not all you'd get. You'd get a potential new therapy, capable of curing Alzheimer's, Lou Gehrig's disease. . .even multiple sclerosis. More >

Micro-Cap E&Ps with Less Risky Businesses: Casimir's Philip Juskowicz
Source: Brian Sylvester of The Energy Report  (12/4/14)
Many small-cap exploration and production companies have had a good run in recent years, but are now getting whacked given their strong connections to oil prices. But the news is not all bad: Philip Juskowicz of Casimir Capital makes a good case for certain micro-cap names. In this exclusive interview with The Energy Report, Juskowicz discusses four companies with strong narratives, two with defensive assets, and notes that natural gas names could see market love as margins widen. More >

Brinson Patrick's Christopher S. James: All Catalysts Are Not Created Equal
Source: George S. Mack of The Life Sciences Report  (12/4/14)
Why do some good-news milestones cause stocks to languish, or even fall? Neurosurgeon Christopher James, managing director and senior biotechnology analyst at Brinson Patrick Securities, performs due diligence on stocks, in part, by connecting his clinical experience to the readiness of physicians and patients to adopt new therapies. In this interview with The Life Sciences Report, James gives real-life examples of catalysts and their effects, and highlights three strong biotech plays that could return multiples of invested capital. More >

Doug Loud and Jeff Mosseri Say Gold Will Regain Its Shine in 2015
Source: Kevin Michael Grace of The Gold Report  (12/3/14)
For all the talk of gold sinking remorselessly to $1,000 an ounce, the metal has risen to $1,200 per ounce and has held its ground. Have we seen the bottom? Money managers Doug Loud and Jeff Mosseri of Greystone Asset Management say that if we haven't seen the bottom, we will soon. In this interview with The Gold Report, they predict that the next bull market will result in patient investors realizing gains in the multiples and suggest several companies poised to break out. More >

Harsh Words on Swiss Gold Referendum
Source: Lawrence Williams, Mineweb  (12/3/14)
"Egon von Greyerz is a firm believer that gold is underpriced at the moment—primarily because it is now so out of sync with the huge amounts of debt built up by governments around the world and the huge amount of money printing to preserve the perception that economies are stable to positive by keeping interest rates at or near zero." More >